Literature DB >> 1855557

Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat.

J R Seckl1, S L Lightman.   

Abstract

Cerebrospinal fluid (CSF) levels of vasopressin (AVP) are elevated in some disorders associated with raised intracranial pressure. We have previously demonstrated that intracerebroventricular infusion of AVP in the conscious goat leads to elevation of intracranial pressure by a mechanism independent of changes in arterial blood pressure or circulating neurohypophysial peptide concentrations. We have now examined the effect of increasing CSF AVP levels on CSF dynamics using the technique of ventriculo-cisternal perfusion in the conscious goat. Intracerebroventricular perfusion with 5 pmol/min AVP in artificial CSF did not alter CSF formation rate but significantly reduced CSF absorption rate (24% decrease; p less than 0.01), when compared with perfusion using artificial CSF alone. This AVP-mediated reduction in CSF absorption rate may represent increased resistance to resorption of CSF or may reflect the effect of raised intracranial pressure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855557     DOI: 10.1007/bf00231772

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  30 in total

1.  Antidiuretic hormone in cerebrospinal fluid during endogenous and exogenous changes in its blood level.

Authors:  H Vorherr; M W Bradbury; M Hoghoughi; C R Kleeman
Journal:  Endocrinology       Date:  1968-08       Impact factor: 4.736

2.  The hypothalamo-choridal tract. II. Ultrastructural response of the choroid plexus to vasopressin.

Authors:  W J Schultz; M S Brownfield; G P Kozlowski
Journal:  Cell Tissue Res       Date:  1977-03-01       Impact factor: 5.249

3.  Cerebrospinal fluid vasopressin in benign intracranial hypertension.

Authors:  P S Sørensen; M Hammer; F Gjerris
Journal:  Neurology       Date:  1982-11       Impact factor: 9.910

4.  Cerebrospinal fluid vasopressin and increased intracranial pressure.

Authors:  P S Sørensen; F Gjerris; M Hammer
Journal:  Ann Neurol       Date:  1984-05       Impact factor: 10.422

5.  Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF.

Authors:  W B Mens; A Witter; T B van Wimersma Greidanus
Journal:  Brain Res       Date:  1983-02-28       Impact factor: 3.252

6.  Cerebrospinal fluid concentration of arginine vasopressin in children with bacterial meningitis.

Authors:  H Garcia; S L Kaplan; R D Feigin
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

7.  Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage.

Authors:  T Dóczi; F A László; P Szerdahelyi; F Joó
Journal:  Neurosurgery       Date:  1984-04       Impact factor: 4.654

8.  The effects of some inhibitors and accelerators of sodium transport on the turnover of 22Na in the cerebrospinal fluid and the brain.

Authors:  H Davson; M B Segal
Journal:  J Physiol       Date:  1970-07       Impact factor: 5.182

9.  Central effects of arginine vasopressin on blood pressure in rats.

Authors:  Q J Pittman; D Lawrence; L McLean
Journal:  Endocrinology       Date:  1982-03       Impact factor: 4.736

10.  Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage.

Authors:  H M Mather; V Ang; J S Jenkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

View more
  2 in total

Review 1.  An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics.

Authors:  Claire A Sheldon; Young Joon Kwon; Grant T Liu; Shana E McCormack
Journal:  Pediatr Res       Date:  2014-11-24       Impact factor: 3.756

Review 2.  Emerging therapeutic targets for cerebral edema.

Authors:  Ruchira M Jha; Sudhanshu P Raikwar; Sandra Mihaljevic; Amanda M Casabella; Joshua S Catapano; Anupama Rani; Shashvat Desai; Volodymyr Gerzanich; J Marc Simard
Journal:  Expert Opin Ther Targets       Date:  2022-01-02       Impact factor: 6.797

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.